MSOS
AdvisorShares Pure US Cannabis ETF [MSOS] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
MSOS Stock Summary
Top 10 Correlated ETFs
MSOS
Top 10 Correlated Stocks
MSOS
In the News
MSOS Financial details
Company Rating
-
Market Cap
1B
Income
-
Revenue
-
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
-
Optionable
No
Shortable
Yes
Earnings
-
P/E
0
Forward P/E
-
PEG
-
P/S
-
P/B
-
P/C
-
P/FCF
-
Quick Ratio
-
Current Ratio
-
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
-6.39%
SMA50
-19.28%
SMA100
-25.88%
Inst Own
-
Inst Trans
-
ROA
-
ROE
-
ROC
-
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
4.78-10.955
52W High
-61.8%
52W Low
-4.5%
RSI
46.89
Rel Volume
0.55
Avg Volume
8.5M
Volume
4.69M
Perf Week
-1.8%
Perf Month
-6.6%
Perf Quarter
-14.16%
Perf Half Y
-17.85%
-
-
-
-
Beta
1.57
-
-
Volatility
0.09%, 0.17%
Prev Close
2.69%
Price
3.82
Change
0.26%
Company Profile
- Volume Average 8.5M
- Market Capitalization 1B
- Headquarters US
- IPO Date 2020-09-02
The fund is an actively managed ETF that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from the marijuana and hemp business in the United States and in derivatives that have economic characteristics similar to such securities. It will concentrate at least 25% of its investments in the pharmaceuticals, biotechnology & life sciences industry group within the health care sector. The fund is non-diversified.
